Robert Ticktin
Vermogen: 119 421 $ op 31-08-2026
Vermogen: 119 421 $ op 31-08-2026
Mr. Robert Ticktin is a COO, Secretary & General Counsel at PMV Pharmaceuticals, Inc. Mr. Ticktin was previously employed as an Associate General Counsel by Tesaro, Inc., a Senior Vice President & General Counsel by EPIRUS Biopharmaceuticals, Inc. /Old/, a Secretary, Senior Vice President & General Counsel by EPIRUS Biopharmaceuticals, Inc., and a Senior Vice President & General Counsel by Zalicus, Inc. He received his undergraduate degree from The Ohio State University and a graduate degree from Fordham University School of Law.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 07-04-2026 | 98.695 ( 0,18% ) | 119 421 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Operationeel Directeur | 01-12-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| TESARO INC | Corporate Officer/Principal | 01-06-2020 |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies | Algemeen Adviseur | 01-08-2016 |
| EPIRUS BIOPHARMACEUTICALS, INC. | Algemeen Adviseur | - |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Algemeen Adviseur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Health Technology |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies | Health Technology |
Fordham University School of Law
Fordham University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EPIRUS Biopharmaceuticals, Inc.
EPIRUS Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biosimilar monoclonal antibodies | Health Technology |
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau